Acadia Healthcare (NASDAQ:ACHC – Get Free Report) will likely be posting its Q3 2026 results after the market closes on Wednesday, November 4th. Analysts expect Acadia Healthcare to post earnings of $0.4625 per share and revenue of $877.76 million for the quarter. Individuals can find conference call details on the company’s upcoming Q3 2026 earnings results page for the latest details on the call scheduled for Thursday, November 5, 2026 at 9:00 AM ET.
Acadia Healthcare Trading Down 1.1%
Shares of ACHC stock opened at $29.62 on Tuesday. The firm has a 50-day moving average price of $29.12 and a 200 day moving average price of $25.72. Acadia Healthcare has a twelve month low of $11.43 and a twelve month high of $35.83. The company has a market capitalization of $2.76 billion, a price-to-earnings ratio of -2.38, a PEG ratio of 9.51 and a beta of 0.63. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 1.20.
Analysts Set New Price Targets
Several equities research analysts have issued reports on the stock. KeyCorp raised their price target on shares of Acadia Healthcare from $30.00 to $40.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 14th. Cantor Fitzgerald reissued a “neutral” rating on shares of Acadia Healthcare in a research report on Tuesday, October 6th. Leerink Partners boosted their price objective on shares of Acadia Healthcare from $30.00 to $33.00 and gave the company a “market perform” rating in a research report on Wednesday, September 23rd. Raymond James Financial downgraded shares of Acadia Healthcare from a “strong-buy” rating to an “outperform” rating and set a $39.00 price objective on the stock. in a research note on Monday, September 28th. Finally, Barclays raised their target price on shares of Acadia Healthcare from $25.00 to $32.00 and gave the stock an “equal weight” rating in a research report on Thursday, July 30th. Eight research analysts have rated the stock with a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, Acadia Healthcare currently has a consensus rating of “Hold” and a consensus price target of $30.69.
Read Our Latest Stock Analysis on Acadia Healthcare
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services headquartered in Franklin, Tennessee. The company operates psychiatric hospitals, specialty treatment facilities and outpatient programs focused on mental health and substance use disorders.
Acadia’s services include inpatient and outpatient psychiatric care, addiction treatment, residential treatment, eating-disorder programs, and services for children and adolescents. Its facilities serve patients with a range of behavioral health conditions, including depression, anxiety, trauma-related disorders and substance use disorders.
Founded in 2005, Acadia operates primarily in the United States and also has a significant presence in the United Kingdom through its ownership of Priory, a behavioral healthcare provider.
Read More
- Five stocks we like better than Acadia Healthcare
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
